(Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Stem Cell Assays Market 2022: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2030

Stem Cell Assays Market 2022: Industry Size, Regions, Emerging Trends,...

Home / Categories / Other
Stem Cell Assays Market 2022: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2030
Stem Cell Assays Market 2022:...
Report Code

Publish Date

$ 4904/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5483/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 8796/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
The global stem cell assay market size was US$ 1,856.4 million in 2021. The global stem cell assay market size is forecast to reach US$ 7,925.2 million by 2030, growing at a compound annual growth rate (CAGR) of 17.5% during the forecast period from 2022 to 2030.

Stem cells are unique biological cells with the capacity to proliferate and give rise to many cell types. Numerous regenerative medical techniques and treatments for many diseases employ stem cells. Many biological and physical characteristics of these cells, including cell size, shape, viability, purity, potency, phenotypic, and others, can be characterized using stem cell assays. In stem cell tests, living cells are analyzed based on many criteria, including shape, size, and others. These assays are widely employed in the development of new medications as diagnostic techniques to assess biochemical and cellular processes utilizing functioning cells.

Factors Influencing Market Growth
The growing awareness about the therapeutic potency of stem cells, rising funding for stem cell research, and increasing demand for cell-based assays in drug discovery drive the global market.

The limited availability of trained and skilled professionals and the high cost of stem cell-based treatments may slow down the overall market growth.

The advent of microfluidics in stem cell research and increasing government initiatives to promote stem cell research are forecast to offer lucrative opportunities for the global market.

Impact Analysis of COVID-19
The COVID-19 pandemic had a negative impact on the global market. Several governments worldwide imposed a lockdown in order to curb the virus from spreading. In addition, many hospitals and clinics have to restructure owing to the rising COVID-19 cases, and doctors concentrated on treating COVID-19 patients. This led to the closure of non-essential hospitals and clinics.

Regional Analysis
The Asia Pacific region accounted for a substantial market share in 2021 and is forecast to remain dominant during the forecast period. As a result of the rising public-private financing to encourage stem cell product research and commercialization and increasing cancer and other illness prevalence. In addition, rising R&D spending on biopharmaceutical undertakings and an increase in focus on developing stem cell-based therapies.

North America is forecast to have considerable growth during the forecast period. As a result of the well-established research infrastructure and the availability of funding and assistance to help the clinical research on stem cells.

Leading Competitors
The leading prominent companies profiled in the global stem cell assays market are:
Dickinson and Company
Danaher Corporation
Thermo Fisher Scientific Inc.
General Electric Company
Merk KGaA
Perkinelmer Inc.
Promega Corporation
Bio-Rad Laboratories Inc.
Other Prominent Players

Scope of the Report
The global stem cell assay market segmentation focuses on Type, Cell Type, Application, End-User, and Region.
Segmentation based on Type
Viability/Cytotoxicity Assays
o Tetrazolium Reduction Assays
o Resazurin Cell Viability Assays
o Calcein-AM Cell Viability Assays
o Other Viability/Cytotoxicity Assays
Isolation & Purification Assays
Cell Identification Assays
Proliferation Assays
Differentiation Assays
Function Assays
Apoptosis Assays
o Caspase Assays
o Annexin V and Cell Permeability Assays
o DNA Fragmentation Assays
o Mitochondrial Assays
Segmentation based on Cell Type
Adult Stem Cells
Mesenchymal Stem Cells
Induced Pluripotent Stem Cells
Hematopoietic Stem Cells
Umbilical Cord Stem Cells
Neural Stem Cells
Human Embryonic Stems Cells
Segmentation based on Application
Regenerative Medicine & Therapy Development
Orthopedic, Musculoskeletal, and Spine Applications
Dermatology Applications
Cardiovascular Applications
CNS Applications
Oncology Applications
Diabetes Applications
Segmentation based on End-User
Biopharmaceutical & Biotechnology Companies
Academic & Research Institutes
Segmentation based on Region
North America
The U.S.
Western Europe
The UK
Rest of Western Europe
Eastern Europe
Rest of Eastern Europe
Asia Pacific
Australia & New Zealand
Rest of Asia Pacific
Middle East & Africa (MEA)
Saudi Arabia
South Africa
Rest of MEA
South America
Rest of South America

Meta Title: Stem Cell Assay Market Size, Share, Insight and Forecast 2022 to 2030
Meta Description: Global Stem Cell Assay Market is projected to reach US$ 7,925.2 million by the end of 2030 from US$ 1,856.4 million in 2021, at a CAGR of 17.5%
Meta Keywords: stem cell assay market Size, stem cell assay market share, stem cell assay market trend, stem cell assay market Forecast, stem cell assay market insight


500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES